Tetralogy of fallot classification: Difference between revisions

Jump to navigation Jump to search
Fahimeh Shojaei (talk | contribs)
Created page with "__NOTOC__ {{Tetralogy of fallot}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There is no established system for the classification of [disease name]. OR [Disease name] may be clas..."
 
Fahimeh Shojaei (talk | contribs)
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}} {{Fs}}
{{CMG}}; {{AE}} {{Fs}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].
<br />
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==
There is no established system for the classification of [disease name].
OR


[Disease name] may be classified according to [classification method] into [number] subtypes/groups:  
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:  
Line 44: Line 14:
*[Group4]
*[Group4]


OR
{|
 
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Subtypes
[Disease name] may be classified into [large number > 6] subtypes based on:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Explanation
*[Classification method 1]
|-
*[Classification method 2]
! style="background: #DCDCDC; text-align: center;" |Acute Motor Axonal Neuropathy (AMAN)
*[Classification method 3]
| style="background: #F5F5F5;" |
 
* The most common type (85-90%).
[Disease name] may be classified into several subtypes based on:
* Prior infection can trigger it.
*[Classification method 1]
* [[Autoimmune disorder]].
*[Classification method 2]
* The target is [[schwann cell]] surface membrane or the [[myelin]].
*[Classification method 3]
* Causes [[demyelination]].
 
* In electrodiagnostic tests we can see slowing of nerve conduction.
OR
* In pathology we can see [[Lymphocyte|lymphocytic]] infiltration of peripheral nerves and [[macrophage]] invasion of [[myelin sheath]] and [[Schwann cell|schwann cells]].
 
|-
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
! style="background: #DCDCDC; text-align: center;" |Acute Motor Axonal Neuropathy (AMAN)
 
| style="background: #F5F5F5;" |
OR
* It’s common among Chinese and Japanese people.
 
* It can be triggered by C. jejuni.
'''If the staging system involves specific and characteristic findings and features:'''
* It is associated with anti[[ganglioside]] [[antibodies]].
 
* [[Autoimmunity|Autoimmune]] disorder.
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
* Target is [[Axon|axonal]] membrane.
 
* Causes [[Axon|axonal]] degeneration in [[Motor neuron|motor neurons]].
OR
* In electrodiagnostic study we can see reduction of compound muscle [[action potential]].
 
|-
The staging of [malignancy name] is based on the [staging system].
! style="background: #DCDCDC; text-align: center;" |Acute motor and sensory axonal neuropathy
 
| style="background: #F5F5F5;" |
OR
* The incidence rate is under 10%.
* Causes [[Axon|axonal]] [[degeneration]].
* It is similar with [[Acute motor axonal neuropathy|AMAN]] but involves both motor and sensory [[Axon|axons]].
|-
! style="background: #DCDCDC; text-align: center;" |Miller Fisher syndrome
| style="background: #F5F5F5;" |
* Causes a clinical triad: [[ophthalmoplegia]], [[ataxia]] and [[areflexia]].
* Associated with [[ganglioside]] GQ1b [[antibody]].
|}


There is no established system for the staging of [malignancy name].


==References==
==References==

Revision as of 17:59, 11 February 2020

Tetralogy of fallot Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tetalogy of Fallot from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Evaluation and Follow-up


Tetralogy of fallot classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tetralogy of fallot classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tetralogy of fallot classification

CDC on Tetralogy of fallot classification

Tetralogy of fallot classification in the news

Blogs on Tetralogy of fallot classification

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tetralogy of fallot classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview


Classification

[Disease name] may be classified according to [classification method] into [number] subtypes/groups:

  • [Group1]
  • [Group2]
  • [Group3]
  • [Group4]
Subtypes Explanation
Acute Motor Axonal Neuropathy (AMAN)
Acute Motor Axonal Neuropathy (AMAN)
Acute motor and sensory axonal neuropathy
Miller Fisher syndrome


References

Template:WH Template:WS